Table 1.
Size (mm) | ZF-Like Cell (Area %) | ZG-Like Cell (Area %) | ZR-Like Cell (Area %) | Histological Diagnosis | CYP11B2 | CYP17A | Somatic Mutation | ||
---|---|---|---|---|---|---|---|---|---|
T1 | 21 × 13 | 85 | 15 | 0 | Adenoma | Heterogeneously positive | (−) | KCNJ5 | L168R |
T2 | 12 × 4 | 0 | 100 | 0 | Adenoma | Homogeneously positive | Weak positive | CACNA1D | G403R |
T3 | 17 × 11 | 0 | 0 | 100 | Adenoma | Positive in 10% of the cells | Weak positive | N/D | N/D |
T4 | 7 × 1 | 90 | 10 | 0 | Adenoma | 50% of ZF-like cells positive | (−) | KCNJ5 | T158A |
T5 | 4 × 3 | 80 | 20 | 0 | Adenoma | (−) | (−) | N/D | N/D |
N1 | Normal | N/D | N/D |
The results of histology, IHC, and targeted next-generation sequencing are shown by each component. The sample numbers match those in Fig. 1(a) and 1(d). Two different KCNJ5 somatic mutations were each identified in two APAs predominantly consisting of ZF-like cells (T1, T4), whereas CACNA1D somatic mutation was detected in the APA predominantly consisting of ZG-like cells (T2). No somatic mutations were detected in the APA with ZR-like cells (T4), the APA without CYP11B2 IHC (T5), and the adjacent normal adrenal tissue (N1). Reference transcript sequences used for determining amino acid changes are as follows: NM_000890.3 (KCNJ5), NM_001128839.2 (CACNA1D), NM_021949.3 (ATP2B3), and NM_000701.7 (ATP1A1).
Abbreviation: N/D, not detected.